Needham & Company LLC Reaffirms “Buy” Rating for Taysha Gene Therapies (NASDAQ:TSHA)
Needham & Company LLC restated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $8.00 target price on the stock. TSHA has been the subject of a number of other reports. JMP Securities increased their target […]
Needham & Company LLC restated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $8.00 target price on the stock. TSHA has been the subject of a number of other reports. JMP Securities increased their target […]
